Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125498951 | 12549895 | 1 | I | 200801 | 20160701 | 20160712 | 20160712 | EXP | FR-INDIVIOR LIMITED-INDV-091927-2016 | INDIVIOR | 37.36 | YR | M | Y | 0.00000 | 20160712 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125498951 | 12549895 | 1 | PS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 2 MG, QID | U | U | UNKNOWN | 20732 | 2 | MG | SUBLINGUAL TABLET | QID | |||
| 125498951 | 12549895 | 2 | SS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Nasal | 2 MG, UNK | U | U | UNKNOWN | 20732 | 2 | MG | SUBLINGUAL TABLET | ||||
| 125498951 | 12549895 | 3 | C | XANAX | ALPRAZOLAM | 1 | Unknown | UNK, 3 TIMES A DAY | 0 | ||||||||||
| 125498951 | 12549895 | 4 | C | SEROPLEX | ESCITALOPRAM OXALATE | 1 | Unknown | 1 DOSAGE FORM/TABLET A DAY | 0 | ||||||||||
| 125498951 | 12549895 | 5 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | 25MG, 2 TABLETS IN THE EVENING | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125498951 | 12549895 | 1 | Drug dependence |
| 125498951 | 12549895 | 3 | Product used for unknown indication |
| 125498951 | 12549895 | 4 | Product used for unknown indication |
| 125498951 | 12549895 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125498951 | 12549895 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125498951 | 12549895 | Headache | |
| 125498951 | 12549895 | Hyposmia | |
| 125498951 | 12549895 | Intentional product misuse | |
| 125498951 | 12549895 | Myalgia | |
| 125498951 | 12549895 | Nasal inflammation | |
| 125498951 | 12549895 | Nasal obstruction | |
| 125498951 | 12549895 | Oedema peripheral | |
| 125498951 | 12549895 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125498951 | 12549895 | 1 | 200801 | 0 | ||
| 125498951 | 12549895 | 2 | 2015 | 0 | ||
| 125498951 | 12549895 | 3 | 2008 | 0 | ||
| 125498951 | 12549895 | 4 | 2008 | 0 | ||
| 125498951 | 12549895 | 5 | 2008 | 0 |